Evidence map›Paper›PMID 38601544›Full record

ArticleHeliyon2024

A retrospective study suggests 55 days of persistence of SARS-CoV-2 during the first wave of the pandemic in Santiago de Chile.

Claudio Acuña-Castillo, Mabel Vidal, Eva Vallejos-Vidal, Roberto Luraschi, Carlos Barrera-Avalos, Ailen Inostroza-Molina, Sonia Molina-Cabrera, Daniel Valdes, Carolina Schafer, Kevin Maisey and 13 more

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 6 institutions in 2 countries.

Claudio Acuña-CastilloCentro de Biotecnología Acuícola, Universidad de Santiago de Chile, Santiago, Chile.
Mabel VidalCentro de Biotecnología Acuícola, Universidad de Santiago de Chile, Santiago, Chile.
Eva Vallejos-VidalCentro de Biotecnología Acuícola, Universidad de Santiago de Chile, Santiago, Chile.
Roberto LuraschiCentro de Biotecnología Acuícola, Universidad de Santiago de Chile, Santiago, Chile.
Carlos Barrera-AvalosCentro de Biotecnología Acuícola, Universidad de Santiago de Chile, Santiago, Chile.
Ailen Inostroza-MolinaCentro de Biotecnología Acuícola, Universidad de Santiago de Chile, Santiago, Chile.
Sonia Molina-CabreraCentro de Salud Familiar San José de Chuchunco, Santiago, Chile.
Daniel ValdesCentro de Biotecnología Acuícola, Universidad de Santiago de Chile, Santiago, Chile.
Carolina SchaferCentro de Biotecnología Acuícola, Universidad de Santiago de Chile, Santiago, Chile.
Kevin MaiseyCentro de Biotecnología Acuícola, Universidad de Santiago de Chile, Santiago, Chile.
Mónica ImaraiCentro de Biotecnología Acuícola, Universidad de Santiago de Chile, Santiago, Chile.
Rodrigo VeraHospital de Urgencia Asistencia Pública (HUAP), Santiago, Chile.
Sergio VargasHospital de Urgencia Asistencia Pública (HUAP), Santiago, Chile.
Leonel E RojoCentro de Biotecnología Acuícola, Universidad de Santiago de Chile, Santiago, Chile.
Elías Leiva-SalcedoDepartamento de Biología, Universidad de Santiago de Chile, Santiago, Chile.
Alejandro EscobarLaboratorio Biología Celular y Molecular, Instituto de Investigación en Ciencias Odontológicas, Universidad de Chile, Santiago, Chile.
Sebastián Reyes-CerpaCentro de Genómica y Bioinformática, Facultad de Ciencias, Ingeniería y Tecnología, Universidad Mayor, Santiago, Chile.
Alexis GaeteLaboratorio de Bioinformática y Expresión Génica, Instituto de Nutrición y Tecnología de Los Alimentos, Universidad de Chile, Santiago, Chile.
Ricardo Palma-VejaresCentro de Modelamiento Matemático UMI-CNRS 2807, Universidad de Chile, Santiago, Chile.
Dante TravisanyFondap Center for Genome Regulation, Universidad de Chile, Santiago, Chile.
Claudio TorresDepartment of Neurobiology Drexel University, Philadelphia, United States.
Felipe E Reyes-LópezCentro de Biotecnología Acuícola, Universidad de Santiago de Chile, Santiago, Chile.
Ana María SandinoCentro de Biotecnología Acuícola, Universidad de Santiago de Chile, Santiago, Chile.
Universidad de Santiago de Chile · CLUniversity of Chile · CLDrexel University · USHospital Dipreca · CLInria Chile · CLUniversidad Mayor · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: As the COVID-19 pandemic persists, infections continue to surge globally. Presently, the most effective strategies to curb the disease and prevent outbreaks involve fostering immunity, promptly identifying positive cases, and ensuring their timely isolation. Notably, there are instances where the SARS-CoV-2 virus remains infectious even after patients have completed their quarantine. Objective: Understanding viral persistence post-quarantine is crucial as it could account for localized infection outbreaks. Therefore, studying and documenting such instances is vital for shaping future public health policies. Design: This study delves into a unique case of SARS-CoV-2 persistence in a 60-year-old female healthcare worker with a medical history of hypertension and hypothyroidism. The research spans 55 days, marking the duration between her initial and subsequent diagnosis during Chile's first COVID-19 wave, with the analysis conducted using RT-qPCR. Results: Genomic sequencing-based phylogenetic analysis revealed that the SARS-CoV-2 detected in both Nasopharyngeal swab samples (NPSs) was consistent with the 20B clade of the Nextstrain classification, even after a 55-day interval. Conclusion: This research underscores the need for heightened vigilance concerning cases of viral persistence. Such instances, albeit rare, might be pivotal in understanding sporadic infection outbreaks that occur post-quarantine.

Indexed as

ChileCOVID-19Health care workerPandemicPhylogenetic analysisSARS-CoV-2Viral persistence

Identifiers

PMID38601544
PMCPMC11004068
OpenAlexW4391065985

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.